Literature DB >> 1850022

Multiple bidirectional initiations and terminations of transcription in the Marek's disease virus long repeat regions.

X B Chen1, L F Velicer.   

Abstract

Marek's disease is an oncogenic disease of chickens caused by a herpesvirus, Marek's disease virus (MDV). Serial in vitro passage of pathogenic MDV results in amplification of a 132-bp direct repeat in the MDV genome's TRL and IRL repeat regions and loss of tumorigenicity. This led to the hypothesis that upon such expansion, one or more tumor-inducing genes fail to be expressed. In this report a group of cDNAs mapping in the expanded regions were isolated from a pathogenic MDV strain in which the 132-bp direct repeat number was found to range between one and seven. Partial cDNA sequencing and S1 nuclease protection analysis revealed that the corresponding transcripts are either initiated or terminated within or near the expanded regions at multiple sites in both rightward and leftward directions. Furthermore, each 132-bp repeat contains one TATA box and two polyadenylation consensus sequences in each direction. These RNAs contain a partial copy or one or more full copies of the 132-bp direct repeat at either their 5' or 3' end. Northern (RNA) blot analysis showed that the majority of transcripts are 1.8 kb in size, while the minor species range in size from 0.67 to 3.1 kb. Together, these data raise the possibility that the 132-bp direct repeat, and indirectly its copy number, may be involved in the regulation of transcriptional initiation and termination and therefore in the generation of four groups of transcripts from the TRL and IRL, although this remains to be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850022      PMCID: PMC240598     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Attenuation of Marek's disease virus and study of its properties in two different cell cultures.

Authors:  K Nazerian
Journal:  J Natl Cancer Inst       Date:  1970-06       Impact factor: 13.506

2.  Identification of the gene encoding Marek's disease herpesvirus A antigen.

Authors:  R J Isfort; H J Kung; L F Velicer
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

3.  Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage.

Authors:  R F Silva; R L Witter
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

4.  Induction of cellular thymidine kinase occurs at the mRNA level.

Authors:  P Stuart; M Ito; C Stewart; S E Conrad
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

5.  Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage.

Authors:  K Maotani; A Kanamori; K Ikuta; S Ueda; S Kato; K Hirai
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

Review 6.  Marek's disease virus.

Authors:  S Kato; K Hirai
Journal:  Adv Virus Res       Date:  1985       Impact factor: 9.937

7.  An antisense mRNA directs the covalent modification of the transcript encoding fibroblast growth factor in Xenopus oocytes.

Authors:  D Kimelman; M W Kirschner
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

8.  The structure of Marek disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA.

Authors:  K Fukuchi; A Tanaka; L W Schierman; R L Witter; M Nonoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

9.  The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter region.

Authors:  G Laux; A Economou; P J Farrell
Journal:  J Gen Virol       Date:  1989-11       Impact factor: 3.891

10.  Stable reduction of thymidine kinase activity in cells expressing high levels of anti-sense RNA.

Authors:  S K Kim; B J Wold
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

View more
  8 in total

1.  The genome of a very virulent Marek's disease virus.

Authors:  E R Tulman; C L Afonso; Z Lu; L Zsak; D L Rock; G F Kutish
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Isolation and characterization of cDNAs from BamHI-H gene family RNAs associated with the tumorigenicity of Marek's disease virus.

Authors:  F Peng; G Bradley; A Tanaka; G Lancz; M Nonoyama
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

3.  Identification of an immediate-early gene in the Marek's disease virus long internal repeat region which encodes a unique 14-kilodalton polypeptide.

Authors:  Y Hong; P M Coussens
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

4.  Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells.

Authors:  Z Z Cui; L F Lee; J L Liu; H J Kung
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

5.  Identification of a unique Marek's disease virus gene which encodes a 38-kilodalton phosphoprotein and is expressed in both lytically infected cells and latently infected lymphoblastoid tumor cells.

Authors:  X B Chen; P J Sondermeijer; L F Velicer
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

6.  Expression of the Marek's disease virus homolog of herpes simplex virus glycoprotein B in Escherichia coli and its identification as B antigen.

Authors:  X Chen; L F Velicer
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

7.  Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek's disease virus 1.

Authors:  Stephen J Spatz; Robert F Silva
Journal:  Virus Genes       Date:  2006-09-09       Impact factor: 2.198

8.  Latent Marek's disease virus can be activated from its chromosomally integrated state in herpesvirus-transformed lymphoma cells.

Authors:  H J Delecluse; S Schüller; W Hammerschmidt
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.